NCT06961279View on ClinicalTrials.gov

Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin Resistance

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 15, 2013

Primary Completion Date

December 15, 2017

Study Completion Date

December 1, 2018

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Resveratrol

Administered orally once every 12 hours

DIETARY_SUPPLEMENT

Placebo

Administered orally once every 12 hours

Trial Locations (1)

Unknown

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER

NCT06961279 - Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin Resistance | Biotech Hunter | Biotech Hunter